Anti-Mda5 Dermatomyositis has emerging NIH research funding with 1 grant totaling $2.5M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Anti-Mda5 Dermatomyositis. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for anti-MDA5 dermatomyositis. Trials may be industry-sponsored or funded through non-NIH sources.
9 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for anti-MDA5 dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
34 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for anti-MDA5 dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
8 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for anti-MDA5 dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
25 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for anti-MDA5 dermatomyositis. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Anti-Mda5 Dermatomyositis.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.